Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial
van de Loosdrecht, A. A., Cremers, E. M. P., Alhan, C., Duetz, C., in ’t Hout, F. E. M., Visser-Wisselaar, H. A., Chitu, D. A., Verbrugge, A., Cunha, S. M., Ossenkoppele, G. J., Janssen, J. J. W. M., Klein, S. K., Vellenga, E., Huls, G. A., Muus, P., Langemeijer, S. M. C., de Greef, G. E., te Boekhorst, P. A. W., Raaijmakers, M. H. G., van Marwijk Kooy, M., Legdeur, M. C., Wegman, J. J., Deenik, W., de Weerdt, O., van Maanen-Lamme, T. M., Jobse, P., van Kampen, R. J. W., Beeker, A., Wijermans, P. W., Biemond, B. J., Tanis, B. C., van Esser, J. W. J., Schaar, C. G., Noordzij-Nooteboom, H. S., Jacobs, E. M. G., de Graaf, A. O., Jongen-Lavrencic, M., Stevens-Kroef, M. J. P. L., Westers, T. M., Jansen, J. H.
Published in Leukemia (01.04.2024)
Published in Leukemia (01.04.2024)
Get full text
Journal Article
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome
Janssen, J. J. W. M., Löwenberg, B., Manz, M., Biemond, B. J., Westerweel, P. E., Klein, S. K., Fehr, M., Sinnige, H. A. M., Efthymiou, A., Legdeur, M. C. J. C., Pabst, T., Gregor, M., van der Poel, M. W. M., Deeren, D., Tick, L. W., Jongen-Lavrencic, M., van Obbergh, F., Boersma, R. S., de Weerdt, O., Chalandon, Y., Heim, D., Spertini, O., van Sluis, G., Graux, C., Stüssi, G., van Norden, Y., Ossenkoppele, G. J.
Published in Leukemia (01.09.2022)
Published in Leukemia (01.09.2022)
Get full text
Journal Article
Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years
Cornelissen, J J, Versluis, J, Passweg, J R, van Putten, W L J, Manz, M G, Maertens, J, Beverloo, H B, Valk, P J M, van Marwijk Kooy, M, Wijermans, P W, Schaafsma, M R, Biemond, B J, Vekemans, M-C, Breems, D A, Verdonck, L F, Fey, M F, Jongen-Lavrencic, M, Janssen, J J W M, Huls, G, Kuball, J, Pabst, T, Graux, C, Schouten, H C, Gratwohl, A, Vellenga, E, Ossenkoppele, G, Löwenberg, B
Published in Leukemia (01.05.2015)
Published in Leukemia (01.05.2015)
Get full text
Journal Article
Sickle cell disease: Clinical presentation and management of a global health challenge
Houwing, M.E., de Pagter, P.J., van Beers, E.J., Biemond, B.J., Rettenbacher, E., Rijneveld, A.W., Schols, E.M., Philipsen, J.N.J., Tamminga, R.Y.J., van Draat, K. Fijn, Nur, E., Cnossen, M.H.
Published in Blood reviews (01.09.2019)
Published in Blood reviews (01.09.2019)
Get full text
Journal Article
Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio
Versluis, J, in ‘t Hout, F E M, Devillier, R, van Putten, W L J, Manz, M G, Vekemans, M -C, Legdeur, M -C, Passweg, J R, Maertens, J, Kuball, J, Biemond, B J, Valk, P J M, van der Reijden, B A, Meloni, G, Schouten, H C, Vellenga, E, Pabst, T, Willemze, R, Löwenberg, B, Ossenkoppele, G, Baron, F, Huls, G, Cornelissen, J J
Published in Leukemia (01.01.2017)
Published in Leukemia (01.01.2017)
Get full text
Journal Article
Web Resource
Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
Ossenkoppele, G. J., Breems, D. A., Stuessi, G., van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B., Graux, C., Huls, G., Janssen, J. J. J. W., Jaspers, A., Jongen-Lavrencic, M., de Jongh, E., Klein, S. K., van der Klift, M., van Marwijk Kooy, M., Maertens, J., Michaux, L., van der Poel, M. W. M., van Rhenen, A., Tick, L., Valk, P., Vekemans, M. C., van der Velden, W. J. F. M., de Weerdt, O., Pabst, T., Manz, M., Löwenberg, B.
Published in Leukemia (01.10.2020)
Published in Leukemia (01.10.2020)
Get full text
Journal Article
Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40
Rijneveld, A W, van der Holt, B, Daenen, S M G J, Biemond, B J, de Weerdt, O, Muus, P, Maertens, J, Mattijssen, V, Demuynck, H, Legdeur, M C J C, Wijermans, P W, Wittebol, S, Spoelstra, F M, Dekker, A W, Ossenkoppele, G J, Willemze, R, Cornelissen, J J
Published in Leukemia (01.11.2011)
Published in Leukemia (01.11.2011)
Get full text
Journal Article
Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso‐occlusive crisis and steady state
Sins, J. W. R., Schimmel, M., Luken, B. M., Nur, E., Zeerleder, S. S., van Tuijn, C. F. J., Brandjes, D. P. M., Kopatz, W. F., Urbanus, R. T., Meijers, J. C. M., Biemond, B. J., Fijnvandraat, K.
Published in Journal of thrombosis and haemostasis (01.07.2017)
Published in Journal of thrombosis and haemostasis (01.07.2017)
Get full text
Journal Article
Therapeutic use of transferrin to modulate anemia and conditions of iron toxicity
Boshuizen, M., van der Ploeg, K., von Bonsdorff, L., Biemond, B.J., Zeerleder, S.S., van Bruggen, R., Juffermans, N.P.
Published in Blood reviews (01.11.2017)
Published in Blood reviews (01.11.2017)
Get full text
Journal Article
Back to base pairs: What is the genetic risk for red bloodcell alloimmunization?
Gerritsma, J.J., Oomen, I., Meinderts, S., van der Schoot, C.E., Biemond, B.J., van der Bom, J.G., Fijnvandraat, K., van Beers, E.J., Biemond, B.J., Beijlevelt, M., Brons, P.P.T., Cnossen, M.H., Dovern, L., Fijnvandraat, K., Heijboer, H., Hofstede, F., Kerkhoffs, J.L.H., Nur, E., Ootjers, C., de Pagter, P.J., Rijneveld, A.W., Schols, S.E.M., Smiers, F.J., Suiker, M.H., Teuben, S.A.M.C., van Tuijn, C.F.J., van Vliet, I., Zwagemaker, E.
Published in Blood reviews (01.07.2021)
Published in Blood reviews (01.07.2021)
Get full text
Journal Article
The practice of platelet transfusion prior to central venous catheterization in presence of coagulopathy: a national survey among clinicians
Weerdt, E. K., Peters, A. L., Goudswaard, E. J., Binnekade, J. M., Lienden, K. P., Biemond, B. J., Vlaar, A. P. J.
Published in Vox sanguinis (01.05.2017)
Published in Vox sanguinis (01.05.2017)
Get full text
Journal Article
S105: ADDING AZATHIOPRINE/HYDROXYUREA PRECONDITIONING TO ALEMTUZUMAB/TBI CONDITIONING IMPROVES DONOR CHIMERISM IN MATCHED SIBLING DONOR STEM CELL TRANSPLANTATION IN ADULT SICKLE CELL DISEASE PATIENTS
Dovern, E, Aydin, M, Tang, M, Suijk, L, Tuijn, C, Zeerleder, S, Hazenberg, M, Biemond, B, Nur, E
Published in HemaSphere (01.01.2022)
Published in HemaSphere (01.01.2022)
Get full text
Journal Article
P‐023: 2,3‐DIPHOSPHOGLYCERATE DETECTION VIA DIRECT INFUSION HIGH RESOLUTION MASS SPECTROMETRY CORRELATES WITH QUANTITATIVE DETECTION IN BLOOD OF PATIENTS WITH SICKLE CELL DISEASE
S., VAN DER VEEN, M., VAN DIJK, J., JANS, N., VERHOEVEN‐DUIF, R., VAN WIJK, M., BARTELS, M., MAÑÚ PEREIRA, R., COLOMBATTI, M., MARTELLA, V., MUNARETO, M., BOARO, P., BARTOLLUCI, M., CNOSSEN, B., BIEMOND, E., VAN BEERS
Published in HemaSphere (16.08.2022)
Published in HemaSphere (16.08.2022)
Get full text
Journal Article
PI‐02: FOLLOW‐UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
M., VAN DIJK, M., RAB, B., VAN OIRSCHOT, J., BOS, C., DERICHS, A., RIJNEVELD, M., CNOSSEN, E., NUR, B., BIEMOND, M., BARTELS, J., JANS, W., VAN SOLINGE, R., SCHUTGENS, R., VAN WIJK, E., VAN BEERS
Published in HemaSphere (16.08.2022)
Published in HemaSphere (16.08.2022)
Get full text
Journal Article
Prevention of catheter‐related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo‐controlled study
NIERS, T. M. H., DI NISIO, M., KLERK, C. P. W., BAARSLAG, H. J., BÜLLER, H. R., BIEMOND, B. J.
Published in Journal of thrombosis and haemostasis (01.09.2007)
Published in Journal of thrombosis and haemostasis (01.09.2007)
Get full text
Journal Article
S118: LONG‐TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN‐LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL
Achebe, M, Nduba, V, Hassab, H, Alkindi, S, Brown, R, Telfer, P, Biemond, B, Gordeuk, V, Lipato, T, Tonda, M, Gray, S, Howard, J
Published in HemaSphere (01.01.2022)
Published in HemaSphere (01.01.2022)
Get full text
Journal Article
P1566: PROTON PUMP INHIBITION FOR SECONDARY HEMOCHROMATOSIS IN HEREDITARY ANEMIA, A PHASE III PLACEBO‐CONTROLLED RANDOMIZED CROSS‐OVER CLINICAL TRIAL
Van Vuren, A., Kerkhoffs, J., Schols, S., Rijneveld, A., Nur, E., Peereboom, D., Gandon, Y., Welsing, P., Wijk, R., Schutgens, R., Solinge, W., Marx, J., Leiner, T., Biemond, B., Beers, E.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article